🔎 Trials Near Me

Hjem › Crohns sykdom › Indiana › Indianapolis

Kliniske studier for Crohns sykdom i Indianapolis, IN

10 studier for Crohns sykdom søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • Indiana University Health University Hospital ( Site 5022), Indianapolis
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekruttererFase 2
  • Indiana University Health University Hospital /ID# 278129, Indianapolis
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548542

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RekruttererFase 3
  • Riley Hospital for Children, Indianapolis
Alder 3 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2/3
  • IU Health University Hospital, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Indiana University Health University Hospital, Indianapolis
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
Alder 2 til 17 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekruttererFase 3
  • Riley Childrens Hospital, Indianapolis
Alder 2 til 17 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis
Alder 2 til 17 · Alle kjønn · Oppdatert 24. jun. 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekruttererFase 4
  • Riley Hospital for Children at Indiana University Health, Indianapolis
Alder 6 til 17 · Alle kjønn · Oppdatert 27. mai 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

RekruttererFase 2/3
  • Riley Hospital for Children, Indianapolis
Alder 6 til 22 · Alle kjønn · Oppdatert 5. mai 2026 · NCT05660746

Crohns sykdom-studier i andre byer

Andre studier i Indianapolis

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.